Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
EMBO Molecular Medicine|January 3, 2025
PlexinD1 is a driver and a therapeutic target in advanced prostate cancerJing Wei, Jing Wang, Wen Guan, et al.
Oncogene|August 19, 2022
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancerJing Wang, Jingjing Li, Lijuan Yin, et al.
Cancer Research|June 25, 2021
Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate CancerJing Wei, Lijuan Yin, Jingjing Li, et al.
Genes & Cancer|March 29, 2011
Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growthJae Yeon Chun, Ramakumar Tummala, Nagalakshmi Nadiminty, et al.
Cancer Genomics & Proteomics|June 13, 2008
Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate CancerHaitao Zhang, Yan Dong, Hongjuan Zhao, et al.
Iscience|January 13, 2021
WLS-Wnt signaling promotes neuroendocrine prostate cancerTyler Bland, Jing Wang, Lijuan Yin, et al.
Cancer Research|April 15, 2010
Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cellsNagalakshmi Nadiminty, Wei Lou, Meng Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Interleukin-6 regulates androgen synthesis in prostate cancer cellsJae Yeon Chun, Nagalakshmi Nadiminty, Smitha Dutt, et al.
The Prostate|September 22, 2012
Functional p53 determines docetaxel sensitivity in prostate cancer cellsChengfei Liu, Yezi Zhu, Wei Lou, et al.
The Journal of Urology|July 12, 2005
Interleukin-6 polymorphism is associated with more aggressive prostate cancerDongfeng Tan, Xiuxian Wu, Min Hou, et al.
Pageof 15